Harbor Capital Advisors »

Kiniksa Pharmaceuticals shares owned by Harbor Capital Advisors

Quarter-by-quarter ownership of Kiniksa Pharmaceuticals shares owned by Harbor Capital Advisors from 13F filings

Historical chart of Harbor Capital Advisors investment in Kiniksa Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Kiniksa Pharmaceuticals held by Harbor Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kiniksa Pharmaceuticals by Harbor Capital Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $804k 21k 38.84
2025-06-30 $2.0M 71k 27.68
2025-03-31 $1.7M 78k 22.21
2024-12-31 $1.9M 98k 19.78
2024-09-30 $2.4M 98k 24.99
2024-03-31 $259k 13k 19.71

More positions owned by Harbor Capital Advisors

iShares S&P 500 Index (IVV)
iShares MSCI Emerging Markets Indx (EEM)
iShares MSCI EAFE Index Fund (EFA)
NVIDIA Corporation (NVDA)
Alphabet Inc Class A cs (GOOGL)
Microsoft Corporation (MSFT)
Apple (AAPL)
Facebook Inc cl a (META)
JPMorgan Chase & Co. (JPM)
Select Sector Spdr Tr Communic etfeqty (XLC)
Home Depot (HD)
Financial Select Sector SPDR (XLF)
Netflix (NFLX)
RadNet (RDNT)
Stonex Group (SNEX)

View all positions for Harbor Capital Advisors

Top funds holding Kiniksa Pharmaceuticals

Birchview Capital
Harbor Capital Advisors

View all funds holding Kiniksa Pharmaceuticals